GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Institutional Ownership

Biohit Oyj (OHEL:BIOBV) Institutional Ownership : 0.06% (As of May. 19, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biohit Oyj's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biohit Oyj's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biohit Oyj's Float Percentage Of Total Shares Outstanding is 0.00%.


Biohit Oyj Institutional Ownership Historical Data

The historical data trend for Biohit Oyj's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Institutional Ownership Chart

Biohit Oyj Historical Data

The historical data trend for Biohit Oyj can be seen below:

2019-02-28 2019-03-31 2019-04-30 2019-05-31 2019-06-30 2019-07-31 2019-08-31 2019-09-30 2019-10-31 2019-11-30
Institutional Ownership 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06

Biohit Oyj Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Biohit Oyj (OHEL:BIOBV) Business Description

Traded in Other Exchanges
N/A
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines